Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · QSK

Hybrid Stent Graft, Thoracic Aortic Lesion Treatment

Repair or replacement of damaged or diseased vessel of the aortic arch and descending thoracic aorta, with or without involvement of ascending aorta, using vascular grafts and/or stent grafts placed during open surgical repair.

Product / regulatory recordCompanyPathwayDecision dateSource
Thoraflex HybridP210006/S018
Vascutek, Ltd.PMA supplementSep 8, 2026FDA
Artivion, IncPMA approvalJun 26, 2026FDA
Thoraflex HybridP210006/S019
Vascutek, Ltd.PMA supplementJun 24, 2026FDA
Thoraflex HybridP210006/S017
Vascutek, Ltd.PMA supplementApr 20, 2026FDA
Thoraflex HybridP210006/S016
Vascutek, Ltd.PMA supplementJan 29, 2026FDA
Thoraflex HybridP210006/S015
Vascutek, Ltd.PMA supplementOct 29, 2025FDA
Thoraflex HybridP210006/S014
Vascutek, Ltd.PMA supplementOct 16, 2025FDA
Thoraflex HybridP210006/S013
Vascutek, Ltd.PMA supplementJul 30, 2025FDA
Vascutek, Ltd.PMA approvalApr 19, 2022FDA
Source information

Follow the FDA links to view the original records.

All device categories